Clinical Trials Browser

Phase 2 × Glioblastoma × regorafenib × Clear all

NCT04051606 2025-06-05

Regorafenib in Bevacizumab Refractory Recurrent Glioblastoma

Phase 2 Completed

Glioblastoma

NCT04704154 2025-04-18

A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can Improve Tumor Responses and How Safe it is for Participants With Solid Tumors

Phase 2 Completed

175 enrolled 20 charts

CNSGastrointestinalHead & Neck

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Astrocytoma, Glioblastoma

NCT02926222 2022-09-09

REGOMA

Phase 2 Completed

Glioblastoma